Top 'ADHD Experts' all take drug company money

Updated: Nov 17

All of the world's ten most influential 'ADHD experts' take funds from multiple ADHD drug manufacturers. Topping the list is American psychologist Prof Stephen V. Faraone who has commercial ties to 21 ADHD drug companies. Faraone has authored or co-authored 325 articles in the last decade at an astonishing rate 0f one every eleven days.

We can't know how much Faraone and his fellow ADHD Industry luminaries get paid but thanks to recent improvements in academic journal conflict of interest disclosure requirements, we do know some of their financial ties. We also know that ADHD is very Big Business with global sales in 2021 expected to total US$22.5 billion.

Some (not all) of the most relevant connections for the world's ten most prominent 'ADHD experts' are listed below. A more comprehensive list (including more 'experts') is available at ADHD "Experts" Conflicts of Interest..

1. Stephen V. Faraone from the USA has authored or co-authored 325 articles on ADHD published between 2011 to 2021. Faraone has received funding support from at least 21 companies who have manufactured or intended to profit from the manufacture of ADHD drugs.

These include: Arbor, Ironshore, Ondosis, Otsuka, Rhodes, Shire/Takeda, Sunovion, Supernus, Tris, and Vallon. Alcobra, Eli Lilly, Enzymotec, Janssen, KemPharm, Lundbeck/Takeda, McNeil, Neurolifesciences, Neurovance, Novartis and Pfizer.

Faraone was elected President of the World Federation of ADHD in 2019. The WF ADHD openly seeks sponsorship but does not publish its funding sources. He is the lead signatory of the the WF ADHD International Consensus Statement published in 2021.

The vast majority of signatories declared financial ties to ADHD drug manufacturers. (Note: In coming months will expose what passes for science in the WF ADHD Consensus Statement.)

2. Samuele Cortese (UK 134 articles) - Shire, Eli Lilly

3. Jan K. Buitelaar (Netherlands 282 articles) - Takeda/Shire, Janssen and Eli Lilly, Lundbeck, Shire, Novartis and Bristol-Myer Squibb, UCB.

4. Philip Asherson (UK 181 articles) - Shire/Takeda, Eli-Lilly, Novartis and Shire.

5. Tobias Banaschewski (Germany 163 articles) - Lundbeck, Shire/Takeda and Janssen, McNeil, Eli Lilly, Novartis, Shire.

6. David Coghill (Australia 99 articles) - Shire/Takeda, Medice and Janssen-Cilag, Eli Lilly, Novartis, Shire.

7. Edmund Sonuga-Barke (Denmark 148 articles) - MRC, Shire/Takeda and Janssen Cilag, Medice.

8. Luis Augusto Rohde (Brazil 156 articles) - Eli-Lilly, Janssen-Cilag, Medice, Novartis, Pfizer, Shire and Abbott, Bristol-Myers Squibb.

9. L Eugene Arnold (USA 106 articles) - Eli Lilly, Neuropharm, Novartis, Noven, Shire, Otsuka, Pfizer, Roche and Tris. Arnold is the only member of the top 10 who was not a signatory to the WF ADHD International Consensus Statement.

10. Henrik Larsson (Sweden 133 articles) - Shire/Takeda and Evolan Pharma.

Similar ADHD drug company ties are evident for the vast majority of the next 57 people listed as leading global 'ADHD Experts' listed by Expertscape. This invites some obvious questions: Can we really trust their work? Are they salespeople or scientists?

By Martin Whitely PhD Editor 16 November 2021

Note: While ADHD is serious (and big) business the Mockumentary ADHD is BS (Attention Deficit Disorder is Behavioural Science) starring Australian comedian Peter Rowsthorn as American 'ADHD Expert' Professor Chip Cash might make you smile.

606 views0 comments